CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (Amex: JAV) today announced that NGN Capital’s co-founder, Georg Nebgen, Ph.D., was unanimously elected to the Board of Directors. Venture capitalist Peter Morgan Kash has stepped down from the board and will continue to serve with the Company under contract.
